HIV vaccine research in Thailand: lessons learned

References

• Phanuphak P, Teeratakulpixarn S, Sarangbin S et al. International clinical trials of HIV vaccines: I. Phase I trial of an HIV-1 synthetic peptide vaccine in Bangkok, Thailand. Asian Pac. J. Allergy Immunol.15(1), 41–48 (1997).
   PubMed Web of Science ®Google Scholar
• Migasena S, Suntharasamai P, Pitisuttithum P et al. AIDSVAX (MN) in Bangkok injecting drug users: a report on safety and immunogenicity, including macrophage-tropic virus neutralization. AIDS Res. Hum. Retroviruses16(7), 655–663 (2000).
   Google Scholar
• Nitayaphan S, Khamboonruang C, Sirisophana N et al. A Phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative thais. AFRIMS-RIHES Vaccine Evaluation Group. Armed Forces Research Institute of Medical Sciences and the Research Institute for Health Sciences. Vaccine18(15), 1448–1455 (2000).
   PubMed Web of Science ®Google Scholar
• Pitisuttithum P, Nitayaphan S, Thongcharoen P et al. Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults. J. Infect. Dis.188(2), 219–227 (2003).
   PubMed Web of Science ®Google Scholar
• Pitisuttithum P, Berman PW, Phonrat B et al. Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1. J. Acquir. Immune Defic. Syndr.37(1), 1160–1165 (2004); erratum in J. Acquir. Immune Defic. Syndr.37(5), 1669 (2004).
   PubMed Web of Science ®Google Scholar
• Wasi C, Sutthent R, Osmanov S. The AIDS epidemic in Thailand: molecular epidemiology of HIV in Thailand. In: HIV Vaccine Research and Development in Thailand. Pitisuttithum P, Francis DP, Esparza J, Thongcharoen P (Eds). Amarin Printing and Publishing Public Company, Bangkok, Thailand 31–50 (2006).
   Google Scholar
• Khamboonruang C. Developing cohorts for Phase III trials of candidate HIV vaccines: Chiang Mai community cohort. In: HIV Vaccine Research and Development in Thailand. Pitisuttithum P, Francis DP, Esparza J, Thongcharoen P (Eds). Amarin Printing and Publishing Public Company, Bangkok, Thailand 221–238 (2006).
   Google Scholar
• Vanichseni S, Kitayaporn D, Mastro TD. Developing cohorts for Phase III trials of candidate HIV vaccines: the Bangkok Metropolitan Administration (BMA) cohort of injecting drug users (IDUs). In: HIV Vaccine Research and Development in Thailand. Pitisuttithum P, Francis DP, Esparza J, Thongcharoen P (Eds). Amarin Printing and Publishing Public Company, Bangkok, Thailand 241–249 (2006).
   Google Scholar
• Benenson MW. Developing cohorts for Phase III trials of candidate HIV vaccines: community cohorts in Rayong and Chon Buri. In: HIV Vaccine Research and Development in Thailand. Pitisuttithum P, Francis DP, Esparza J, Thongcharoen P (Eds). Amarin Printing and Publishing Public Company, Bangkok, Thailand 251–261 (2006).
   Google Scholar
• Pitisuttithum P, Gilbert P, Gurwith M et al. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J. Infect. Dis.194(12), 1661–1671 (2006).
   PubMed Web of Science ®Google Scholar
• van Griensvan F, Keawkungwal J, Tappero JW et al. Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX B/E HIV vaccine trial in Bangkok, Thailand. AIDS18(2), 295–301 (2004).
   PubMed Web of Science ®Google Scholar
• Suntharasamai P, Martin M, Vanichseni S et al. Incarceration and the risk for HIV infection among injection drug users participating in an HIV vaccine trial in Bangkok, 1999–2003 (2008) (In press).
   Google Scholar
• Pitisuttithum P, Choopanya K, Bussaratid V et al. Social harms in injecting drug users participating in the first Phase III HIV vaccine trial in Thailand. J. Med. Assoc. Thai.90(11), 2441–2448 (2007).
   Google Scholar
• Suriyanon V, Gurunathan S, Thongcharoen P et al. Safety and tolerability of live recombinant ALVAC-HIV (vCP1521) priming with either gp160 or gp120 boosting in Thai seronegative. Presented at: 6th International Congress on AIDS in Asia and the Pacific. Melbourne, Australia, 5–10 October, 2001.
   Google Scholar
• Nitayaphan S, Pitisuttithum P, Karnasuta C et al. Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults. J. Infect. Dis.190(4), 702–706 (2004).
   PubMed Web of Science ®Google Scholar
• Rerks-Ngarm S, Chunsuttiwat S, Pitisuttithum P et al. Thai prime–boost HIV vaccine Phase III trial: update 2007. Presented at: AIDS Vaccine 2007. Seattle, WA, USA, 20–23 August, 2007.
   Google Scholar
• Pitisuttithum P, Rerks-Ngarm S, Kaewkungwal J et al. Women participation in the Phase III efficacy trial of ALVAC HIV-1 vaccine priming, AIDSVAX vaccine boosting in Thailand. Presented at: AIDS Vaccine 2007. Seattle, WA, USA, 20–23 August, 2007.
   Google Scholar
• Premsri N, Namwat C, Rerks-Ngarm S et al. Integration of community engagement activities support the prime–boost Phase III HIV vaccine trial in Thailand. Presented at: AIDS Vaccine 2007. Seattle, WA, USA, 20–23 August, 2007.
   Google Scholar
• Hammer S, Miller M, Pape J et al. Safety and immunogenicity of the MRKAd5 gag HIV-1 vaccine in a worldwide Phase I study of healthy adults (Merck V520–018/HVTN 050). Presented at: AIDS Vaccine 2007. Seattle, WA, USA, 20–23 August, 2007.
   Google Scholar
• Steinbrook R. One step forward, two steps back – will there ever be an AIDS vaccine? N. Engl. J. Med.357(26), 2653–2655 (2007).
   PubMed Web of Science ®Google Scholar
• Pitisuttithum P. HIV vaccine research in Thailand national perspective: overview of HIV vaccine research in Thailand. In: HIV Vaccine Research and Development in Thailand. Pitisuttithum P, Francis DP, Esparza J, Thongcharoen P (Eds). Amarin Printing and Publishing Public Company, Bangkok, Thailand 83–92 (2006).
   Google Scholar